deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT00794339

Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer (ACRIN6682)

Copper Cu 64-ATSM and PET/CT Scan in Predicting Disease Progression in Patients With Newly-Diagnosed Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Undergoing Chemoradiotherapy Per NCCN Guidelines

Sponsor: American College of Radiology

Conditions Cervical Cancer
Interventions 64Cu-ATSM FDG
Updated 12 times since 2017 Last updated: Aug 9, 2023 Started: Jul 29, 2009 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

transfer of funding

Other terminated trials from American College of Radiology

See all terminations from American College of Radiology

Other Cervical Cancer trials with similar outcome

Browse all Cervical Cancer trials

Listed as NCT00794339, this PHASE2 trial focuses on Cervical Cancer and remains terminated or withdrawn. Sponsored by American College of Radiology, it has been updated 12 times since 2009, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshotUnknown Status~Apr 2017 – ~Jun 2018 · 14 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshotActive Not Recruiting~Apr 2019 – ~Jan 2021 · 21 months · monthly snapshotUnknown Status~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotUnknown Status~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshotTerminated~Mar 2021 – ~Sep 2023 · 30 months · monthly snapshotTerminated~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

12 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  4. Sep 2023 — Jul 2024 [monthly]

    Terminated PHASE2

  5. Mar 2021 — Sep 2023 [monthly]

    Terminated PHASE2

▶ Show 7 earlier versions

  1. Feb 2021 — Mar 2021 [monthly]

    Terminated PHASE2

    Status: Unknown Status → Terminated

  2. Jan 2021 — Feb 2021 [monthly]

    Unknown Status PHASE2

  3. Apr 2019 — Jan 2021 [monthly]

    Unknown Status PHASE2

    Status: Active Not Recruiting → Unknown Status

  4. Jun 2018 — Apr 2019 [monthly]

    Active Not Recruiting PHASE2

  5. Apr 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

    Status: Unknown Status → Active Not Recruiting

  6. Feb 2017 — Apr 2017 [monthly]

    Unknown Status PHASE2

  7. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE2

    First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • American College of Radiology
  • American College of Radiology Imaging Network
  • National Cancer Institute (NCI)
Data source: American College of Radiology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations